novavax covid vaccine

Order byBest matchMost fresh

FDA, Novavax and Covid-19

After delay, FDA approves Novavax’s Covid-19 vaccine, but only for older people and those at high risk

After a six-week delay, the US Food and Drug Administration has approved Novavax’s Covid-19 vaccine, according to a letter from the agency, but only for people 65 and older and those 12 and up who hav...

WebMD · 4d

FDA Approves Novavax COVID Vaccine With Restricted Use

STAT · 1d

FDA gives Covid vaccine manufacturers instructions for next fall’s shot

MIT Technology Review · 1d

The FDA plans to limit access to covid vaccines. Here’s why that’s not all bad.

Covid vaccines will soon be required to go through more rigorous trials to ensure that they really are beneficial for people who aren’t at high risk.

KPBS · 22h

Experts warn new FDA COVID vaccine policy overlooks long-term risks

Alaska Dispatch News · 1d

Opinion: The FDA’s new covid vaccine policy is clear as mud

F.D.A. Approves Novavax Covid Vaccine With Stricter New Conditions

The agency narrowed who can get the shot and added new study requirements that could cost the company tens of millions.

BioPharma Dive5d

Novavax’s COVID vaccine gets FDA approval, but with limits

While the clearance is only for use in certain groups, Novavax’s long-awaited OK is still seen by analysts as a “win” for the company.

5don MSN

Novavax shares jump after long-awaited FDA approval of its COVID-19 vaccine

Novavax shares jumped more than 15% on Monday after the company secured a long-awaited U.S. regulatory approval for its COVID-19 vaccine, albeit with new conditions, which helped allay some investor concerns over the future of the shot.

1don MSN

FDA advisers recommend updating COVID shots to JN.1 strain

Moderna (MRNA), and Novavax (NVAX) agree as the FDA advisors recommend targeting JN.1 strain for updated COVID vaccines this fall. Read more here.

5don MSN

RFK Jr. pledged not to upend US vaccine system, but big changes are underway

WASHINGTON — Robert F. Kennedy Jr. clinched the political support needed to become the nation’s top health official by pledging to work within the decades-old federal system for approval and use of vaccines. Yet his regulators are promising big changes that cloud the outlook for what shots might even be available.